logo
Plus   Neg
Share
Email

AstraZeneca Covid Vaccine Trials Halted On Children And Teenagers By Oxford

The University of Oxford reported on Tuesday that it is halting the trial of the COVID vaccine developed by AstraZeneca PLC (AZN) on children and teenagers. The vaccine, developed in collaboration with AstraZeneca and Oxford, is under scrutiny for resulting in blood clots in the recipients.

The pediatric trial started in mid-February with 200 youths in the age range of 6-17 in mind, will await the reports of the Medicines and Healthcare products Regulatory Agency before resumption. However, Oxford has not revealed the number of children administered with the shot as of now.

This latest news rams another blow at the AstraZeneca vaccine which has been circulated in more than 70 countries till now. The company was also planning to gain permission to use the vaccine in the US from July.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
A third of those American adults now refusing to get vaccinated would get vaccinated if they could take a pill instead of getting the vaccine shot, according to a poll conducted by Quadrant Strategies and commissioned by biotechnology company Vaxart, Inc. A pill vaccine is expected to overcome vaccine resistance of millions of Americans. While reporting financial results for the first quarter on Thursday, Biogen Inc. (BIIB) raised its adjusted earnings guidance for the full-year 2021, but maintained revenue outlook. For fiscal 2021, the company raised its adjusted earnings guidance to a range of $17.50 to $19.00 per share from the... While reporting financial results for the first quarter on Thursday, electric utility American Electric Power Co., Inc. (AEP) reaffirmed its fiscal 2021 operating earnings guidance in the range of $4.55 to $4.75 per share. Including special items, estimated earnings would be between $4.56 and $4.76 per...
Follow RTT